Leadership

Marty Landon

  • CEO, BioBridge Global

 Martin “Marty” J. Landon has 30 years of experience in the health care industry. Landon has held senior positions in public and private companies and is recognized for building and leading high-performance teams and value-creating initiatives. In 2016, he joined BioBridge Global as chief executive officer. Landon serves on the board of BioMed SA and the San Antonio Medical Foundation

Landon began his career as an internal auditor at the University of Texas Health Science Center at San Antonio and later was an auditor for four years at public accounting firm Arthur Andersen & Co. In 1987, Landon joined Intelogic Trace, a NYSE-traded firm, where he was appointed chief financial officer. 

From 1994 to 2012, Landon was an executive at Kinetic Concepts Inc., now Acelity, a global medical device company, where he led numerous acquisitions, financial and securities transactions. He developed major process improvements and IT initiatives that contributed to extraordinary growth, culminating in a $6.3 billion leveraged buyout. During his tenure at KCI, annual revenues increased from $250 million to nearly $2 billion. 

Prior to his current role, Landon served as president and CEO of CeloNova BioSciences Inc., an early-stage, innovative medical device company that develops, manufactures and sells products with multiple vascular applications. Landon remains a member of the CeloNova board of directors. 

Landon was a Certified Public Accountant from 1984 to 2010 and received his BA in accounting from Benedictine College in Kansas. Landon is a member of the advisory council of SAMMinistries in San Antonio, Texas, chair of the UTSA Research External Advisory Council and a member of the board of visitors at Southwestern University in Georgetown, Texas. 

Rachel-Louise Beddard, MD

  • Sr. Vice President, Chief Medical Officer

Dr. Beddard joined South Texas Blood & Tissue Center as the VP, Medical Affairs on August 2007. Prior to joining our organization, she worked for Johns Hopkins University as an Immunology Laboratory Research Associate, Tidewater Blood Research Laboratory, as the Medical Director, and Texas Cord Blood Bank, as the Medical Director. 

Dr. Beddard received her undergraduate degree from the University of Virginia and her graduate degree from Eastern Virginia Medical School. She has licensures from Virginia, Texas, Georgia, and New York. She is also board certified in Clinical Pathology and Transfusion Medicine.

 

Granville C. Betton

  • Sr. Vice President, Chief Administrative Officer

Mr. Betton has 30 years of experience in operations, manufacturing, services, quality, safety, and process improvement and has successfully guided teams across multiple global locations, driven revenue growth and ensured excellence in service delivery.

After graduating from Rensselaer Polytechnic Institute with a Bachelor of Science in Chemical Engineering, he worked for DuPont in Delaware and Mississippi before joining GE in 1990. He spent the next 24 years in GE working for GE in its Plastics, Medical Systems, and Silicones businesses. Over the course of his 24 years with GE, he held many positions of increasing complexity and responsibility. In 2014 he moved to Houston TX where he worked for Nexeo Solutions, InterWrap, Inc. and Gulf Coast Regional Blood Center before joining BioBridge global in October 2017.

 

Becky Butler Cap

  • Sr. Vice President, Chief Operating Officer, GenCure

Becky Cap, a 20-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February, 2016. GenCure, a subsidiary of BioBridge Global, is focused on providing and developing regenerative medicine and cellular therapy products. GenCure’s mission is to realize the potential of donated human cells and tissue to save and enhance lives.

Cap, a native of Texas, earned a bachelor’s degree from Harvard University. She began her career at Dana-Farber Cancer Institute in Boston, where she gained clinical, laboratory and regulatory experience. She developed her foundational knowledge of clinical medicine in the context of managing clinical trials focused on exploring the benefits of hematologic stem cell transplant for breast cancer and the effects of growth factors in high-dose chemotherapy trials.

While pursuing her MBA at Boston University’s Health Care Management Program, she moved to industry and began working for Eidetics, a consulting firm focused on informing biomedical product development support.  She supported US and global development and strategic marketing efforts for chemotherapeutics, leading monoclonal antibodies, tyrosine kinase inhibitors and bio-oncology agents, including PD-1 and PDL-1 inhibitors.  Her expertise was honed as Oncology became an active and competitive “market” in which physicians and patients had multiple treatment options available to them for their cancers.  Hers was one of the first Oncology Consulting Practices in this strategic marketing and market research space.  She also has run her own consulting firm and worked with a number of local startups in the San Antonio community.

Cap has provided strategic guidance for the development of pharmaceuticals and medical devices, both in large, established firms and early stage ventures.  She has provided extensive entrepreneurial coaching. She is an active member of local and national committees on Regenerative Medicine and Cell Therapy, two private company Boards of Directors and the Governing Committee for Seton Home. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.

Ward Carter

  • Sr. Vice President, Chief Operating Officer, QualTex Laboratories

Ward Carter was named COO of QualTex Laboratories in February 2016. Carter had more than 31 years of experience in the laboratory diagnostics division with Abbott Laboratories, with a longtime emphasis on sales, sales management, product development, commercial operations and customer service.  He was responsible for implementing new commercial sales and marketing processes specific to customer contract and pricing development, along with ongoing customer contract and entitlement management.  Carter was also directly involved in development of commercial compliance initiatives, including customer reporting processes and new ethics and compliance guidelines specifically for the commercial organization.

At numerous points during his career with Abbott, Carter was directly involved in working with blood bank donor screening and safety testing customers, as well as with high-volume diagnostics testing laboratories. Prior to his retirement from Abbott Laboratories, Carter had general management responsibility for the US Transfusion business for Abbott Diagnostics Division.

Carter was the recipient of numerous sales, marketing, and operations awards during his tenure with Abbott, including receiving the Abbott Chairman’s Award, which was directly related to developing and negotiating a large national contract for blood donor testing.  The operations awards received recognized his ability to develop new procedures, and execute changes effectively, while maintaining and building customer satisfaction and loyalty. 

At QualTex, Carter has been instrumental in expanding the capacity footprint and introducing new products and services that expand the customer service offering, while at the same time ensuring that quality is core to everything the QualTex team delivers.

With facilities in San Antonio and Atlanta, QualTex Laboratories is one of the largest independent nonprofit biologic testing centers in the United States. It performs advanced testing services for blood, plasma and tissue donations, as well as testing to support cellular therapy and cell manufacturing, in addition to reference testing and clinical research.  As of January 2018, QualTex Atlanta is the first blood, tissue and plasma collection biologic safety testing laboratory to implement a fully automated sample management system.

Glenn Kues

  • Sr. Vice President and Chief Financial Officer

Glenn Kues joined BioBridge Global in December 2017. Glenn has over 35 years of experience in finance, operations, and technology. Most recently, Glenn was Chief Financial Officer for San Antonio based Renaissance Pharmaceuticals/DPT Laboratories, an integrated pharmaceutical company with both proprietary products and CDMO services. Glenn was with Renaissance/DPT 21 years and held responsibilities for finance, legal, information technology and purchasing.

After graduating from Trinity University with a Bachelor of Science, degree in Computer Science and Accounting Glenn began his career with the international accounting firm KPMG. He has also worked for three privately held contract-manufacturing companies as well as a private holding company. Glenn is a San Antonio native and has had the good fortune of spending the majority of his life in our great city.

Elizabeth Waltman

  • Sr. Vice President, Chief Operating Officer, South Texas Blood & Tissue Center

Elizabeth Waltman joined the organization in January, 2013. Waltman manages all areas of blood operations, including the departments of donor services, donor recruitment, product management, component laboratory, hospital services and operations integration, as well as the Victoria facility.

With over 17 years of experience in executive management, Waltman has previously held positions in recruitment, quality assurance, corporate communications and project management. Most recently, she has worked in management roles with Blood Systems, Inc. and was previously with Gulf Coast Regional Blood Center. She began her career in the health care industry as a nurse in labor and delivery.

Waltman has a Masters in Business Administration from the University of Phoenix and a Bachelor of Arts from University of St. Thomas. She is the South Central Association of Blood Banks (SCABB) Foundation Treasurer and is an active member in the American College of Healthcare Executives, the American Blood Bank Society as well as other professional health care organizations.

William-Richey-Wyatt-Leadership

William "Richey" Wyatt

  • Sr. Vice President, General Counsel, & Chief Compliance Officer

Richey Wyatt joined BioBridge Global on November 30, 2017.  Richey has an extensive legal background, first as a corporate attorney with the law firm Strasburger & Price, LLP (formerly Oppenheimer, Blend, Harrison and Tate, Inc.), where he was a partner and shareholder, respectively, and more recently as Sr. Vice President and General Counsel for a group of health care related entrepreneurial ventures, including Axis Diagnostics, a toxicology screening laboratory headquartered in San Antonio.

Richey received his undergraduate degree from Vanderbilt University (double majoring in English & Philosophy) and his law degree, with honors, from the University of Houston Law Center. Richey is very involved in the San Antonio community having served on various community and non-profit boards as well as in Leadership San Antonio (a leadership program jointly sponsored by the San Antonio Chamber of Commerce & the San Antonio Hispanic Chamber of Commerce). Currently, Richey services on the boards of the San Antonio Museum of Art and the San Antonio North Texans Youth Soccer Club. Richey is married to Joan and has two sons, Henry & Taylor.